The second group, novel PTVs, comprised 27 variants in 27 carriers and yielded four individuals: three with hypobetalipoproteinemia, all with various novel truncating mutations in APOB, and one individual with hypertrophic cardiomyopathy and frameshift deletion in MYH7 (Table 6). Here, MYH7 is linked to hypobetalipoproteinemia.